Perez EA - Search Results

1

N0539 phase II trial of fulvestrant and bevacizumab in patients with metastatic breast cancer previously treated with an aromatase inhibitor: a North Central Cancer Treatment Group (now Alliance) trial.

Tan WW, Dueck AC, Flynn P, Steen P, Anderson D, Rowland K, Northfelt D, Perez EA. Tan WW, et al. Among authors: perez ea. Ann Oncol. 2013 Oct;24(10):2548-2554. doi: 10.1093/annonc/mdt213. Epub 2013 Jun 24. Ann Oncol. 2013. PMID: 23798616 Free PMC article. Clinical Trial.

2

Paclitaxel plus nonanthracycline combinations in metastatic breast cancer.

Perez EA. Perez EA. Semin Oncol. 1999 Feb;26(1 Suppl 2):21-6. Semin Oncol. 1999. PMID: 10190781 Review.

3

Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer.

Ingle JN, Suman VJ, Johnson PA, Krook JE, Mailliard JA, Wheeler RH, Loprinzi CL, Perez EA, Jordan VC, Dowsett M. Ingle JN, et al. Among authors: perez ea. Clin Cancer Res. 1999 Jul;5(7):1642-9. Clin Cancer Res. 1999. PMID: 10430063 Clinical Trial.

4

Current management of metastatic breast cancer.

Perez EA. Perez EA. Semin Oncol. 1999 Aug;26(4 Suppl 12):1-10. Semin Oncol. 1999. PMID: 10482189 Review.

5

A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinoma.

Perez EA, Hillman DW, Stella PJ, Krook JE, Hartmann LC, Fitch TR, Hatfield AK, Mailliard JA, Nair S, Kardinal CG, Ingle JN. Perez EA, et al. Cancer. 2000 Jan 1;88(1):124-31. doi: 10.1002/(sici)1097-0142(20000101)88:1<124::aid-cncr17>3.3.co;2-6. Cancer. 2000. PMID: 10618614 Clinical Trial.

6

Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer.

Bonner JA, Sloan JA, Rowland KM Jr, Klee GG, Kugler JW, Mailliard JA, Wiesenfeld M, Krook JE, Maksymiuk AW, Shaw EG, Marks RS, Perez EA. Bonner JA, et al. Among authors: perez ea. Clin Cancer Res. 2000 Feb;6(2):597-601. Clin Cancer Res. 2000. PMID: 10690544 Clinical Trial.

7

Update on metastatic breast cancer.

Perez EA. Perez EA. Curr Oncol Rep. 1999 Sep;1(1):11-5. doi: 10.1007/s11912-999-0004-8. Curr Oncol Rep. 1999. PMID: 11122792 Review. No abstract available.

8

Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancer.

Perez EA, Vogel CL, Irwin DH, Kirshner JJ, Patel R. Perez EA, et al. J Clin Oncol. 2001 Nov 15;19(22):4216-23. doi: 10.1200/JCO.2001.19.22.4216. J Clin Oncol. 2001. PMID: 11709565 Clinical Trial.

9

Rationale and design of a phase III trial of adjuvant sequential epirubicin/ cyclophosphamide and taxane versus concurrent epirubicin/taxane in operable node-positive breast cancer.

Perez EA. Perez EA. Clin Breast Cancer. 2000 Sep;1 Suppl 1:S52-6. doi: 10.3816/cbc.2000.s.010. Clin Breast Cancer. 2000. PMID: 11970750 Review.

10

Weekly paclitaxel in women age 65 and above with metastatic breast cancer.

Perez EA, Vogel CL, Irwin DH, Kirshner JJ, Patel R. Perez EA, et al. Breast Cancer Res Treat. 2002 May;73(1):85-8. doi: 10.1023/a:1015230212550. Breast Cancer Res Treat. 2002. PMID: 12083634 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

627 results

Search Page

Filters